Cytochrome P450 Reference Tables



 

Table 1. CYP3A4 Substrates
Alfentanil Cyclobenzaprine Ketoconazole Sertraline 
Alprazolam Cyclophosphamide Lansoprazole (minor) Tacrolimus
Amitriptyline (minor) Cyclosporine Losartan Tamoxifen 
Amlodipine Dapsone Lovastatin Temazepam 
Astemizole Dexamethasone  Mibefradil Terfenadine
Atorvastatin Dextromethorphan  Miconazole Testosterone
Busulfan Etoposide  Paclitaxel Triazolam 
Cannabinoids Felodipine  Pravastatin Verapamil 
Carbamazepine Fentanyl  Prednisone Vinblastine
Cisapride Fexofenadine  Quinidine Vincristine
Clindamycin Ifosamide  Quinine  R-warfarin
Clomipramine Imipramine  Ritonavir Zileuton
Clonazepam Indinavir  Rifampin   
Cocaine Isradipine  Saquinavir   

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112. Warfarin exists as two isomers, R-warfarin and D-warfarin. R-warfarin is less pharmacologically active than S-warfarin. Significant interactions have resulted from changes in the metabolism of either isomer.
 
 
 
 
 

Table 2. CYP3A4 Inducers
Carbamazepine  Primidone 
Dexamethasone Rifabutin
Ethosuximide Rifampin
Phenobarbital Troglitazone
Phenytoin

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 
 
 

Table 3. CYP3A4 Inhibitors
Amiodarone  Mibefradil 
Cannabinoids  Miconazole
Clarithromycin Nefazodone 
Erythromycin Nelfinavir 
Fluconazole Norfloxacin 
Fluoxetine Omeprazole (slight) 
Fluvoxamine Quinine 
Grapefruit juice Ritonavir 
Indinavir Saquinavir 
Itraconazole Sertraline? 
Ketoconazole  Troleandomycin
Metronidazole  Zafirlukast 

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 

Table 4. CYP2D6 Substrates
Amitriptyline Donepezil Meperidine Propafenone 
Bisoprolol Doxepin Methadone Propranolol 
Chlorpromazine Flecainide Methamphetamine Risperidone 
Clomipramine Fenfluramine Metoprolol Thioridazine 
Clozapine Fluphenazine Mexiletine Timolol 
Codeine Fluoxetine Morphine Tramadol 
Cyclobenzaprine Haloperidol Nortriptyline Trazodone 
Desipramine Hydrocodone Oxycodone Venlafaxine 
Dexfenfluramine Imipramine Paroxetine
Dextromethorphan Maprotiline Perphenazine  

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 

Table 5. CYP2D6 Inducers
Carbamazepine  Rifampin
Phenobarbital  Ritonavir
Phenytoin   

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 

Table 6. CYP2D6 Inhibitors
Amiodarone  Mibefradil
Cimetidine  Paroxetine
Clomipramine  Propafenone
Desipramine Quinidine
Fluoxetine Ritonavir 
Fluphenazine Sertraline 
Haloperidol  Thioridazine

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 
 
 

Table 7. CYP1A2 Substrates
Amitriptyline Desipramine Theophylline
Caffeine Diazepam R-warfarin
Clomipramine Haloperidol Zileuton
Clozapine Imipramine  
Cyclobenzaprine Tacrine  

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 

Table 8. CYP1A2 Inducers
Phenobarbital Ritonavir
Phenytoin Smoking / PAH
Rifampin

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 
 
 

Table 9. CYP1A2 Inhibitors
Cimetidine Isoniazid
Ciprofloxacin Ketoconazole
Clarithromycin Levofloxacin
Enoxacin Norfloxacin
Erythromycin Omeprazole?
Fluvoxamine (potent) Paroxetine
Grapefruit juice

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 
 
 
 
 

Table 10. CYP2C Substrates
Amitriptyline Omeprazole
Clomipramine Phenytoin (2C9)
Diazepam Topiramate (2C19)
Imipramine Tolbutamide
Losartan (2C9) S-warfarin(2C9)

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 

Table 11. CYP2C Inducers
Carbamazepine 
Phenobarbital 
Phenytoin 
Rifampin 

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.
 
 
 

Table 12. CYP2C Inhibitors
Amiodarone (2C9)  Isoniazid 
Chloramphenicol (2C9)  Ketoconazole (weak) 
Cimetidine (2C9)  Omeprazole (2C9, 2C19) 
Fluconazole  Sertraline 
Fluoxetine  Topiramate (2C19) 
Fluvastatin  Zafirlukast (2C9) 
Fluvoxamine (2C9)  

Adapted From: Michalets EL. Pharmacotherapy 1998;18(1):84-112.